Olga Montvida

Retrospective cohort study evaluating the efficacy and safety of an orthopaedic consultant-led virtual fracture clinic in an Australian level 1 trauma centre

Bernarda Cavka, Emily Cross, Olga Montvida, George Plunkett, Andrew Oppy, Andrew Bucknill, Thomas Treseder

Journal article  |  2021  |  ANZ JOURNAL OF SURGERY

BACKGROUND: In Australian health care, the consistent rise in demand for orthopaedic outpatient clinic services is creating marked..

The association of amputations and peripheral artery disease in patients with type 2 diabetes mellitus receiving sodium-glucose cotransporter type-2 inhibitors: real-world study

Sanjoy K Paul, Deepak L Bhatt, Olga Montvida

Journal article  |  2021  |  EUROPEAN HEART JOURNAL

AIMS: The aim of this study was to evaluate the temporal pattern of amputations in patients with type 2 diabetes mellitus (T2DM), ..

Therapeutic inertia in the management of dyslipidaemia and hypertension in incident type 2 diabetes and the resulting risk factor burden: Real-world evidence from primary care

Joanna ZJ Ling, Olga Montvida, Kamlesh Khunti, Anthony L Zhang, Charlie C Xue, Sanjoy K Paul

Journal article  |  2021  |  DIABETES OBESITY & METABOLISM

OBJECTIVE: To investigate trends in the prevalence of hypertension and dyslipidaemia in incident type 2 diabetes (T2DM), time to a..

Temporal trends in co-morbidities and cardiometabolic risk factors at the time of type 2 diabetes diagnosis in the UK

Joanna Ling, Digsu Koye, Luke Buizen, Kamlesh Khunti, Olga Montvida, Sanjoy K Paul

Journal article  |  2021  |  DIABETES OBESITY & METABOLISM

AIM: To evaluate temporal patterns in co-morbidities, cardiometabolic risk factors and a high atherosclerotic cardiovascular disea..

Association of Cardiometabolic Multimorbidity and Depression With Cardiovascular Events in Early-Onset Adult Type 2 Diabetes: A Multiethnic Study in the US

John Epoh Dibato, Olga Montvida, Francesco Zaccardi, Jack Alistair Sargeant, Melanie J Davies, Kamlesh Khunti, Sanjoy K Paul

Journal article  |  2021  |  DIABETES CARE

OBJECTIVE: To evaluate the temporal patterns of cardiometabolic multimorbidity (CM) and depression in White Caucasians (WCs) and A..

Association of biological antirheumatic therapy with risk for type 2 diabetes: a retrospective cohort study in incident rheumatoid arthritis

Sanjoy K Paul, Olga Montvida, Jennie H Best, Sara Gale, Attila Petho-Schramm, Khaled Sarsour

Journal article  |  2021  |  BMJ OPEN

OBJECTIVE: To explore possible associations of treatment with biological disease-modifying antirheumatic drugs (bDMARDs), includin..

Cardiometabolic risk factor control in black and white people in the United States initiating sodium-glucose co-transporter-2 inhibitors: A real-world study

Olga Montvida, Subodh Verma, Jonathan E Shaw, Sanjoy K Paul

Journal article  |  2020  |  DIABETES OBESITY & METABOLISM

AIMS: To explore cardiometabolic risk profiles, the probability of sustainable control, and the effectiveness of treatment with so..

Temporal Trend in Young-Onset Type 2 Diabetes-Macrovascular and Mortality Risk: Study of UK Primary Care Electronic Medical Records

Digsu N Koye, Joanna Ling, John Dibato, Kamlesh Khunti, Olga Montvida, Sanjoy K Paul

Journal article  |  2020  |  DIABETES CARE

OBJECTIVE: To evaluate temporal prevalence trend, cardiometabolic risk factors, and the risk of atherosclerotic cardiovascular dis..

Evaluating the Representativeness of US Centricity Electronic Medical Records With Reports From the Centers for Disease Control and Prevention: Comparative Study on Office Visits and Cardiometabolic Conditions

Olga Montvida, John Epoh Dibato, Sanjoy Paul

Journal article  |  2020  |  JMIR MEDICAL INFORMATICS

BACKGROUND: Electronic medical record (EMR)-based clinical and epidemiological research has dramatically increased over the last d..

Third-Line Antidiabetic Therapy Intensification Patterns and Glycaemic Control in Patients with Type 2 Diabetes in the USA: A Real-World Study

Digsu N Koye, Olga Montvida, Sanjoy Ketan Paul

Journal article  |  2020  |  DRUGS

BACKGROUND: Third-line antidiabetic drug (ADD) intensification patterns and glycemic control post intensification in type 2 diabet..